tirzepatide and semaglutide injections vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Semaglutide vs Tirzepatide: Effectiveness, Side

Retatrutide (LY3437943) is an unlicensed investigational triple GIP, GLP-1, and glucagon receptor agonist with no MHRA or EMA marketing authorisation

Jun 9, 2026 Jun 9, 2026 7 min You hit your goal weight

Wegovys approval as a prescription for cardiovascular disease followed findings from the Select trial, of 17,604 participants across 41 countries including Australia

Most Semaglutide formulations, such as Ozempic and Wegovy, are given once weekly, on the same day each week, with or without meals

The FDA approval for Zepbound covers two distinct indications: For chronic weight management BMI of 30 or higher (clinical obesity), regardless of other health conditions

MF contributed critically to the improvement and editing the manuscript